Copyright
©2008 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. May 28, 2008; 14(20): 3165-3173
Published online May 28, 2008. doi: 10.3748/wjg.14.3165
Published online May 28, 2008. doi: 10.3748/wjg.14.3165
Treatment and survival in a population-based sample of patients diagnosed with gastroesophageal adenocarcinoma
Deirdre P Cronin-Fenton, Limin X Clegg, Surveillance Research Program, DCCPS, National Cancer Institute, Bethesda MD 20892-7344, United States
Deirdre P Cronin-Fenton, Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Alle 43-45, 8200 Aarhus N, Denmark
Margaret M Mooney, CTEP, DCTD, National Cancer Institute, Bethesda
Linda C Harlan, Applied Research Program, DCCPS, National Cancer Institute, Bethesda MD 20892-7344, United States
Limin X Clegg, Office of Healthcare Inspections, Office of Inspector General, Department of Veterans Affairs, Washington DC 20420, United States
Author contributions: Harlan LC designed research; Cronin-Fenton DP, Clegg LX and Harlan LC analyzed the data; Cronin-Fenton DP, Harlan LC and Mooney MM wrote the paper.
Correspondence to: Dr. Linda C Harlan, Applied Research Program, DCCPS, National Cancer Institute, 6130 Executive Blvd MSC 7344, Bethesda MD 20892-7344, United States. lh50w@nih.gov
Telephone: +1-301-4967085
Fax: +1-301-4353710
Received: September 27, 2007
Revised: April 12, 2008
Accepted: April 19, 2008
Published online: May 28, 2008
Revised: April 12, 2008
Accepted: April 19, 2008
Published online: May 28, 2008
Core Tip